Bernstein Research
-
{
- All
- News
-
Nifty May Breach 23,000 Around Lok Sabha Poll Results On June 4: Report
A short-term rally either leading into elections or the week after results could potentially push the Nifty beyond 23,000, international research firm Bernstein said.
-
Unapproved Drugs Found In Weight Loss, Diet And Sex Supplements: Study
Researchers found unapproved and sometimes dangerous drugs in 746 dietary supplements, almost all of them marketed for sexual enhancement, weight loss or muscle growth.
-
James Allison, Tasuku Honjo Win Nobel Prize In Medicine For Cancer Immunotherapy
The American and Japanese researchers discovered methods of removing the brakes on cells that fight invaders, paving the way for cancer immunotherapy, which has joined surgery, radiation and chemotherapy as a major weapon in the battle against cancer.
-
'Reliance Jio May Begin Operations With Disruptive Offers'
Bernstein Research in its report said Reliance Jio would aim at jumping into the top three position by quickly capturing customers.
-
BlackBerry shares jump a week after new launch
Shares of BlackBerry rose more than 12 percent after Bernstein Research said it was upgrading the stock to outperform.
-
Apple may be considering stock split: Bernstein
Bernstein Research on Tuesday wrote that Apple Inc may be considering a stock split.
-
Nifty May Breach 23,000 Around Lok Sabha Poll Results On June 4: Report
A short-term rally either leading into elections or the week after results could potentially push the Nifty beyond 23,000, international research firm Bernstein said.
-
Unapproved Drugs Found In Weight Loss, Diet And Sex Supplements: Study
Researchers found unapproved and sometimes dangerous drugs in 746 dietary supplements, almost all of them marketed for sexual enhancement, weight loss or muscle growth.
-
James Allison, Tasuku Honjo Win Nobel Prize In Medicine For Cancer Immunotherapy
The American and Japanese researchers discovered methods of removing the brakes on cells that fight invaders, paving the way for cancer immunotherapy, which has joined surgery, radiation and chemotherapy as a major weapon in the battle against cancer.
-
'Reliance Jio May Begin Operations With Disruptive Offers'
Bernstein Research in its report said Reliance Jio would aim at jumping into the top three position by quickly capturing customers.
-
BlackBerry shares jump a week after new launch
Shares of BlackBerry rose more than 12 percent after Bernstein Research said it was upgrading the stock to outperform.
-
Apple may be considering stock split: Bernstein
Bernstein Research on Tuesday wrote that Apple Inc may be considering a stock split.
